Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline

International Journal of Antimicrobial Agents

Volumn 45, Issue 4, 2015, Pages 427-429

  Cunha, Burke A ^a,b   Gran, Arthur ^a,b   Raza, Muhammad ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Antibiotic tissue penetration; MDROs; Oral antibiotic therapy; Urinary tract infections

Indexed keywords

DOXYCYCLINE; FOSFOMYCIN; NITROFURANTOIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIURIA; CASE REPORT; CHRONIC PROSTATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; URINALYSIS; URINE CULTURE; DRUG COMBINATION; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; PROSTATITIS; SECRETION (PROCESS); TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DOXYCYCLINE; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FOSFOMYCIN; HUMANS; MALE; MIDDLE AGED; PROSTATITIS; TREATMENT OUTCOME;

EID: 84925517684     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.12.019     Document Type: Article

References (15)

1. B.A. Cunha, and J.B. Comer Pharmacokinetic considerations in the treatment of urinary tract infections Conn Med 43 1979 347 353
2. B.A. Cunha Antibiotic tissue penetration Bull NY Acad Med 59 1983 443 449
3. A.M. Ristuccia, and B.A. Cunha Current concepts in antimicrobial therapy of prostatitis Urology 20 1982 338 345
4. B.A. Cunha Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations J Chemother 23 2011 171 174
5. B.A. Cunha, and S.M. Garabedian-Ruffalo Tetracyclines in urology: current concepts Urology 36 1990 548 556
6. M.E. Falagas, A.C. Kastoris, A.M. Kapaskelis, and D.E. Karageorgopoulos Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review Lancet Infect Dis 10 2010 43 50
7. D. Fournier, C. Chirouze, J. Leroy, P. Cholley, D. Talon, and P. Plésiat Alternatives to carbapenems in ESBL-producing Escherichia coli infections Med Mal Infect 43 2013 62 66
8. B.A. Cunha Antibiotic essentials 12th ed. 2013 Jones & Bartlett Sudbury, MA 110 111 (595-7, 617-8)
9. N. Frimodt-Møller Fosfomycin M.L. Grayson, S.M. Crowe, J.S. McCarthy, J. Mills, J.W. Mouton, S.R. Norrby, Kucers' the use of antibiotics 6th ed. 2010 Arnold London, UK 935 943
10. B.J. Gardiner, A.A. Mahony, A.G. Ellis, N. Lawrentschuk, D.M. Bolton, and P.T. Zeglinski Is fosfomycin a potential treatment alternative for multidrug-resistant Gram-negative prostatitis? Clin Infect Dis 58 2014 e101 e105
11. D.R. Eisen Doxycycline M.L. Grayson, S.M. Crowe, J.S. McCarthy, J. Mills, J.W. Mouton, S.R. Norrby, Kucers' the use of antibiotics 6th ed. 2010 Arnold London, UK 851 869
12. Å. Östholm Balkhed, M. Tärnberg, H.J. Monstein, A. Hällgren, H. Hanberger, and L.E. Nilsson High frequency of co-resistance in CTX-M-producing Escherichia coli to non-β-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden Scand J Infect Dis 45 2013 271 278
13. N.K. Shrestha, D. Amuh, M.P. Goldman, W.J. Riebel, and W.J. Tomford Treatment of a complicated vancomycin-resistant enterococcal urinary tract infection with fosfomycin Infect Dis Clin Pract 9 2000 368 371
14. B.A. Lipsy, I. Byren, and C.T. Hoey Treatment of bacterial prostatitis Clin Infect Dis 50 2010 1641 1642
15. C. Pulcini, K. Bush, W.A. Craig, N. Frimodt-Møller, M.L. Grayson, and J.W. Mouton ESCMID Study Group for antibiotic policies. Forgotten antibiotics: an inventory in Europe, the United States, Canada and Australia Clin Infect Dis 54 2012 268 274